Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study

被引：5

作者：

Qiang, Judy K. ^{[1
]}

Shahbaz, Ali ^{[2
]}

Kim, Whan ^{[3
]}

Marinas, Joseph ^{[3
]}

Greaves, Simon ^{[4
]}

Yeung, Jensen ^{[5
]}

机构：

[1] Univ Toronto, Fac Med, Toronto, ON M5S 1B2, Canada

[2] Univ Ottawa, Sch Med, Ottawa, ON K1N 6N5, Canada

[3] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada

[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1B2, Canada

[5] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON M5S 1B2, Canada

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 01期

关键词：

TO-SEVERE PSORIASIS; ETANERCEPT; EFFICACY;

D O I：

10.1016/j.jaad.2015.08.030

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：176 / 177

页数：3

共 50 条

[21] Cost effectiveness analysis of biologics for the treatment of moderate-to severe plaque psoriasis in Hong Kong
Fung, J.
Chan, W.
Wu, J.
Pang, H.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 62 - 62
[22] Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis
Armstrong, April
Levi, Eugenia
JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (12) : 1240 - 1245
[23] Sequential use of biologics in moderate-to-severe plaque psoriasis: case studies illustrating an individualized approach
Goodfield, M.
BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 21 - 26
[24] Real-world durability of effectiveness through 24 months of anti-interleukin-17A biologics and other approved biologics in treating patients with moderate-to-severe psoriasis in the Psoriasis Study of Health Outcomes
Tijoe, Milan
Costanzo, Antonio
Carrascosa, Jose Manuel
Bovenschen, Hendrik Jorn
Maul, Julia-Tatjana
de Hoog, Niek
Martimianaki, Georgia
Lampropoulou, Anastasia
McKenzie, Robert
Pinter, Andreas
Evans, Josie
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[25] MACEs Not Associated With the Use of Biologic Therapy for Psoriasis in Real-World Clinical Practice: A Canadian Multicenter Retrospective Study
Kim, Whan B.
Qiang, Judy
Yeung, Jensen
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2016, 20 (04) : 352 - 353
[26] Efficacy and safety of secukinumab (IL-17A inhibitor) in treating moderate to severe plaque psoriasis in real-world clinical practice: A Canadian multicenter retrospective study
Georgakopoulos, Jorge-Ryan
Ighani, Arvin
Yeung, Jensen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB114 - AB114
[27] Real-world dermatology visit in moderate to severe plaque psoriasis patients treated with biologics or apremilast
Wu, Jashin J.
Zhang, Jingchuan
Zhao, Yang
Martinez, Diane
Lopez-Gonzalez, Lorena
Marchlewicz, Elizabeth H.
Shrady, George
Mendelsohn, Alan
Feldman, Steven
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB80 - AB80
[28] Trends in the use of biologics for treatment of plaque psoriasis in the real-world setting
Rasouliyan, Lawrence
Althoff, Amanda G.
Kumar, Vikas
Zema, Carla
Long, Stacey
Rao, Mitesh B.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 485 - 485
[29] Characteristics and treatment pattern comparisons of a real-world cohort of patients eligible and ineligible for moderate-to-severe psoriasis clinical trials
Wu, J.
Araujo, A.
Nordstrom, B.
Goldblum, O.
Solotkin, K.
Lin, C. -Y.
Johnston, J.
Kistler, K.
Fraeman, K.
Malatestinic, W.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 84 - 84
[30] Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: A Canadian multicentre retrospective study
Marinas, Joseph E. C.
Kim, Whan B.
Shahbaz, Ali
Qiang, Judy K.
Greaves, Simon
Yeung, Jensen
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 (01) : E11 - E14

← 1 2 3 4 5 →